Immunovant, Inc. (IMVT) Misses Q1 EPS by 15c
Immunovant, Inc. (NASDAQ: IMVT) reported Q1 EPS of ($0.75), $0.15 worse than the analyst estimate of ($0.60).
For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.
Immunovant, Inc. (NASDAQ: IMVT) reported Q1 EPS of ($0.75), $0.15 worse than the analyst estimate of ($0.60).
For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.